Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19
Emmanuel Q Wey, Clare Bristow, Aarti Nandani, Bryan O’Farrell, Jay Pang, Marisa Lanzman, Shuang Yang, Soo Ho, Damien Mack, Michael Spiro, Indran Balakrishnan, Sanjay Bhagani, View ORCID ProfileGabriele Pollara
doi: https://doi.org/10.1101/2021.07.03.21259949
Emmanuel Q Wey
1Department of Infection, Royal Free London NHS Trust, London, UK
2Centre for Clinical Microbiology, Division of Infection & Immunity, UCL, London, UK
Clare Bristow
1Department of Infection, Royal Free London NHS Trust, London, UK
Aarti Nandani
3Department of Pharmacy, Royal Free London NHS Trust, London, UK
Bryan O’Farrell
3Department of Pharmacy, Royal Free London NHS Trust, London, UK
Jay Pang
3Department of Pharmacy, Royal Free London NHS Trust, London, UK
Marisa Lanzman
3Department of Pharmacy, Royal Free London NHS Trust, London, UK
Shuang Yang
4Clinical Practice Group, Analysis Division, Transplant and Specialist Services & Women and Children, Royal Free London NHS Trust, London, UK
Soo Ho
1Department of Infection, Royal Free London NHS Trust, London, UK
Damien Mack
1Department of Infection, Royal Free London NHS Trust, London, UK
Michael Spiro
5Division of Surgery and Interventional Science, University College London, UK
Indran Balakrishnan
1Department of Infection, Royal Free London NHS Trust, London, UK
Sanjay Bhagani
1Department of Infection, Royal Free London NHS Trust, London, UK
Gabriele Pollara
1Department of Infection, Royal Free London NHS Trust, London, UK
6Division of Infection & Immunity, University College London, UK
Article usage
Posted July 07, 2021.
Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19
Emmanuel Q Wey, Clare Bristow, Aarti Nandani, Bryan O’Farrell, Jay Pang, Marisa Lanzman, Shuang Yang, Soo Ho, Damien Mack, Michael Spiro, Indran Balakrishnan, Sanjay Bhagani, Gabriele Pollara
medRxiv 2021.07.03.21259949; doi: https://doi.org/10.1101/2021.07.03.21259949
Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19
Emmanuel Q Wey, Clare Bristow, Aarti Nandani, Bryan O’Farrell, Jay Pang, Marisa Lanzman, Shuang Yang, Soo Ho, Damien Mack, Michael Spiro, Indran Balakrishnan, Sanjay Bhagani, Gabriele Pollara
medRxiv 2021.07.03.21259949; doi: https://doi.org/10.1101/2021.07.03.21259949
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (193)
- Cardiovascular Medicine (2858)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12565)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4438)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2854)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4200)
- Nursing (222)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6786)
- Radiology and Imaging (1491)
- Respiratory Medicine (901)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)